SCHEMBL6901176

SCHEMBL6901176

O=C1c2cccc(O)c2C(=O)c2c1ccc(O)c2O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.77
ALDH1A1 P00352 5/20 0.77
MAPT P10636 5/20 0.77
MAPK1 P28482 4/20 0.77
HPGD P15428 4/20 0.77
ALOX15 P16050 4/20 0.77
HSD17B10 Q99714 4/20 0.77
TDP1 Q9NUW8 4/20 0.77
SMN1; SMN2 Q16637 3/20 0.77
TSHR P16473 3/20 0.77
LMNA P02545 2/20 0.77
MAOB P27338 2/20 0.77
HTT P42858 1/20 0.77
MEN1 O00255 5/20 0.72
KMT2A Q03164 5/20 0.72
KDM4E B2RXH2 4/20 0.72
CYP3A4 P08684 4/20 0.72
RECQL P46063 4/20 0.72
APEX1 P27695 2/20 0.72
ALOX12 P18054 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29929513 1.00 MAOA (0.77) MAOAALDH1A1MAPTMAPK1HPGD
SCHEMBL29929596 0.94 MAOA (0.76) MAOAALDH1A1MAPTMAPK1HPGD
SCHEMBL30695841 0.94 MAOA (0.76) MAOAALDH1A1MAPTMAPK1HPGD
SCHEMBL3185453 0.94 MAOA (0.76) MAOAALDH1A1MAPTMAPK1HPGD
Quinalizarin SCHEMBL9308575 0.93 MAOA (0.80) MAOAALDH1A1MAPTMAPK1HPGD
Anthrarufin SCHEMBL9308318 0.93 MAPT (0.86) MAOAALDH1A1MAPTMAPK1HPGD
SCHEMBL6904748 0.88 MAPT (0.83) MAOAALDH1A1MAPTMAPK1HPGD
Danthron SCHEMBL30544826 0.88 MAPT (1.00) MAOAALDH1A1MAPTMAPK1HPGD
Danthron SCHEMBL29356886 0.88 MAPT (1.00) MAOAALDH1A1MAPTMAPK1HPGD
Danthron SCHEMBL83688 0.88 MAPT (1.00) MAOAALDH1A1MAPTMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 EP claimed
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 EP disclosed
CN-107847466-B Formulations and methods for modulating wound healing 贝欧曼蒂克丝公司 2024-02-06 CN disclosed
US-11786481-B2 Formulation and process for modulating wound healing BioMendics, LLC (US) 2023-10-17 US disclosed
US-20230130406-A1 Redox Flow Battery Electrolytes CMBLU PROJEKT AG (DE) 2023-04-27 US disclosed
US-20230130406-A1 Redox Flow Battery Electrolytes CMBLU PROJEKT AG (DE) 2023-04-27 US disclosed
US-11142827-B2 Fluoride-free zirconium-based metal pre-treatment for passivation HENKEL AG & CO. KGAA (DE) 2021-10-12 US disclosed
US-20210228501-A1 Formulation and Process for Modulating Wound Healing BioMendics, LLC (US) 2021-07-29 US disclosed
CN-108699699-B Fluoride-free zirconium-based metal pretreatment for passivation 汉高股份有限及两合公司 2021-07-20 CN disclosed
EP-3426822-B1 FLUORIDE-FREE ZIRCONIUM-BASED METAL PRE-TREATMENT FOR PASSIVATION HENKEL AG & CO KGAA (DE) 2020-10-21 EP disclosed
US-20160296477-A1 Formulation and Process for Modulating Wound Healing BioMendics, LLC (US) 2016-10-13 US disclosed
WO-2016164531-A2 FORMULATION AND PROCESS FOR MODULATING WOUND HEALING BioMendics, LLC (US) 2016-10-13 WO disclosed
US-9291923-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2016-03-22 US disclosed
US-20150268569-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2015-09-24 US disclosed
US-7658937-B2 Anthraquinones and process for the preparation and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2010-02-09 US disclosed
US-6815481-B2 FUSED DIBENZO THERMAL STABILIZERS SUCH AS ANTHRACENE, XANTHENE AND ANTHRONE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-09 US disclosed
US-20020032256-A1 Polybutadiene composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-14 US disclosed
EP-0320227-B1 Method of preventing polymer-scale formation SHINETSU CHEMICAL CO (JP) 1994-09-07 EP disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786481-B2 Formulation and process for modulating wound healing SQSTM1, ATG7, TFEB MAOA 4700/4885ALDH1A1 2877/4885MAPT 3534/4885
US-20160296477-A1 Formulation and Process for Modulating Wound Healing SQSTM1, ATG7, TFEB MAOA 4676/4885ALDH1A1 2491/4885MAPT 3766/4885
US-20210228501-A1 Formulation and Process for Modulating Wound Healing ATG7, SQSTM1, ATF4 MAOA 4389/4885ALDH1A1 2362/4885MAPT 3091/4885
US-20230130406-A1 Redox Flow Battery Electrolytes GPX1, GPX4, NOX4 MAOA 281/4885ALDH1A1 260/4885MAPT 3707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.